According to Zacks, “BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel. “
BRAINSWAY LTD/S stock traded down $0.18 during trading hours on Friday, reaching $8.95. 1,000 shares of the stock were exchanged, compared to its average volume of 10,479. BRAINSWAY LTD/S has a 52-week low of $8.00 and a 52-week high of $12.39. The company’s 50 day moving average price is $9.08.
Institutional investors have recently made changes to their positions in the business. Delek Group Ltd. purchased a new position in BRAINSWAY LTD/S during the 2nd quarter worth $3,176,000. ARK Investment Management LLC purchased a new position in BRAINSWAY LTD/S during the 2nd quarter worth $863,000. Victory Capital Management Inc. purchased a new position in BRAINSWAY LTD/S during the 2nd quarter worth $157,000. Finally, Noked Capital LTD purchased a new position in BRAINSWAY LTD/S during the 2nd quarter worth $572,000. Institutional investors own 10.84% of the company’s stock.
BRAINSWAY LTD/S Company Profile
Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.
Further Reading: What is an inverted yield curve?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.